Mark Aguillard

Mark Aguillard

Corporate Officer/Principal at DERMTECH, INC.

Net worth: 28 350 $ as of 30/05/2024

Health Technology
Consumer Services
Technology Services

Network origin in Mark Aguillard first degree

EntityEntity typeIndustry
Public Company Medical Specialties 18
1
Holding Company Medical Specialties 1
1
Holding Company Information Technology Services 1

Chart of Companies connected to the second degree

Multi-company connection

Companies connected to Mark Aguillard via their personal network

CompanySectorRelated peopleMain position
Medical Specialties

Cynthia Collins

Matthew Posard

Herm Rosenman

Burkhard Jansen

James Rock

Claudia Ibarra

Kevin Sun

Director/Board Member

Chairman

Director/Board Member

Chief Tech/Sci/R&D Officer

Chief Tech/Sci/R&D Officer

Chief Operating Officer

Director of Finance/CFO

MYRIAD GENETICS, INC. Medical Specialties

Mark Capone

Bret Christensen

Loren Clarke

Steven Stone

Chief Executive Officer

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Medical Specialties

Kirk Malloy

Matthew Posard

Kevin Sun

Chief Tech/Sci/R&D Officer

Sales & Marketing

Corporate Officer/Principal

DEXCOM, INC. Medical Specialties

Kevin Sun

Rachel Williams

Director of Finance/CFO

Corporate Officer/Principal

Miscellaneous Commercial Services

David King

Mark Capone

Chairman

Director/Board Member

ORGANOVO HOLDINGS, INC. Biotechnology

Kirk Malloy

Steve Kunszabo

Chairman

Investor Relations Contact

Medical Specialties

Matthew Posard

Herm Rosenman

Sales & Marketing

Director of Finance/CFO

ILLUMINA, INC. Biotechnology

Kirk Malloy

Matthew Posard

Corporate Officer/Principal

Corporate Officer/Principal

VIVUS, INC. Pharmaceuticals: Major

Herm Rosenman

Director/Board Member

Medical Specialties

Herm Rosenman

Director/Board Member

Electronic Production Equipment

Herm Rosenman

Founder

MEDISTEM INC Medical Specialties

Herm Rosenman

Director/Board Member

OXFORD IMMUNOTEC GLOBAL PLC Medical Specialties

Herm Rosenman

Director/Board Member

NATERA, INC. Medical Specialties

Herm Rosenman

Director/Board Member

Investment Managers

Herm Rosenman

Chief Executive Officer

Medical/Nursing Services

Herm Rosenman

Director/Board Member

Medical Specialties

Herm Rosenman

Director/Board Member

Medical Specialties

Herm Rosenman

Director/Board Member

Wireless Telecommunications

Steve Kunszabo

Investor Relations Contact

IRIDIUM COMMUNICATIONS INC. Specialty Telecommunications

Steve Kunszabo

Investor Relations Contact

The Wharton School of the University of Pennsylvania College/University

Herm Rosenman

Masters Business Admin

ARYX THERAPEUTICS, INC. Pharmaceuticals: Major

Herm Rosenman

Director/Board Member

Ultra Acquisition Corp.

Herm Rosenman

Chief Executive Officer

TALIS BIOMEDICAL CORPORATION Medical Specialties

Matthew Posard

Director/Board Member

Panavance Therapeutics, Inc.

Cynthia Collins

Director/Board Member

Information Technology Services

Cynthia Collins

Director/Board Member

HALOZYME THERAPEUTICS, INC. Biotechnology

Matthew Posard

Director/Board Member

University of California San Diego College/University

Matthew Posard

Undergraduate Degree

CARDIFF ONCOLOGY, INC. Medical Specialties

Matthew Posard

Corporate Officer/Principal

Packaged Software

Matthew Posard

Director/Board Member

Packaged Software

Matthew Posard

President

Miscellaneous Commercial Services

Matthew Posard

Chairman

INFINITY PHARMACEUTICALS, INC. Pharmaceuticals: Major

Herm Rosenman

Director/Board Member

Miscellaneous Commercial Services

Matthew Posard

Director/Board Member

Information Technology Services

Matthew Posard

Chairman

NAUTILUS BIOTECHNOLOGY, INC. Biotechnology

Matthew Posard

Chairman

Explore DNA

Matthew Posard

Corporate Officer/Principal

Biotechnology

Matthew Posard

Director/Board Member

Packaged Software

Matthew Posard

Director/Board Member

Pace University College/University

Herm Rosenman

Undergraduate Degree

METACRINE, INC. Biotechnology

Steve Kunszabo

Investor Relations Contact

NIRI San Diego

Steve Kunszabo

Director/Board Member

University of Vienna College/University

Burkhard Jansen

Corporate Officer/Principal

Medical/Nursing Services

Burkhard Jansen

Chief Executive Officer

DERMIRA, INC. Pharmaceuticals: Major

Ray Bassi

Sales & Marketing

Statistics

International

United States 48
United Kingdom 3
Austria 2

Sectoral

Health Technology 25
Commercial Services 6
Technology Services 6
Consumer Services 5
Health Services 3

Operational

Director/Board Member 85
Corporate Officer/Principal 36
Independent Dir/Board Member 23
Chairman 18
Director of Finance/CFO 17